plasmaMATCH

The UK plasma based Molecular profiling of Advanced breast cancer to inform Therapeutic Choices (plasmaMATCH) Trial: A multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening

Existing samples:

  • Malignant tumor of breast (disorder)

Bespoke collection capabilities:

  • Malignant tumor of breast (disorder)

Contact Information

Email:
plasmamatch-icrctsu@icr.ac.uk
Address:

The Institute of Cancer Research Clinical Trials & Statistics Unit (ICR-CTSU)
Sir Richard Doll Building
15 Cotswold Road
Sutton, Surrey
Surrey
SM2 5NG
England

Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A
2020 N/A N/A N/A N/A N/A N/A
2021 N/A N/A N/A N/A N/A N/A
2022 N/A N/A N/A N/A N/A N/A
2023 N/A N/A N/A N/A N/A N/A
2024 N/A N/A N/A N/A N/A N/A